Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats

被引:10
|
作者
Chen, Kaizhen [1 ]
Teo, Shiyi [1 ]
Seng, Kok -Yong [1 ]
机构
[1] DSO Natl Labs, Def Med & Environm Res Inst, Bioengn Lab, Singapore 117510, Singapore
关键词
Acetylcholinesterase; allometric scaling; diisopropylfluorophosphate; physiologically-based pharmacokinetic and pharmacodynamic model; sensitivity analysis; RISK-ASSESSMENT; INHIBITION; ACETYLCHOLINESTERASE; PLASMA; SOMAN; EXPOSURE; FORMS;
D O I
10.1080/15376510903300335
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A physiologically-based pharmacokinetic and pharmacodynamic (PBPK/PD) model was recently developed to study the effect of diisopropylfluorophosphate (DFP) on acetylcholinesterase (AChE) activity in mouse and rat. That model takes into account relatively complex interactions involving many parameters, some of which may be uncertain and/or highly variable, especially those characterizing AChE activity after DFP intoxication. The primary objective of this study was to identify parameters that contribute most to the variability of AChE dynamics for model optimization against data. For this purpose, the influence of the variability of the rate constants for synthesis (K-syn) and degradation (K-deg) of AChE, and regeneration (K-reg) and aging (K-age) of inhibited AChE on the variability of AChE activity in mice and rat venous blood and brain was first calculated by a global sensitivity analysis. Next, the mouse PBPK/PD model was calibrated by optimizing the values of K-syn, K-deg, K-reg and K-age. Thereafter, scale-up of the DFP-induced AChE activity was performed from mouse to rat. Validation of the rat model was performed by comparing the time course of venous blood and brain AChE activities from a Monte Carlo analysis to those obtained in vivo. Sensitivity analysis on the verified models showed that K-reg and K-syn were the most influential factors of AChE activity at shorter and longer durations, respectively, after DFP challenge. Scale-up of the AChE dynamics from mouse to rat was also successful, as evidenced by significant overlapping between the predicted 95(th) percentile confidence intervals and the experimental data.
引用
收藏
页码:486 / 497
页数:12
相关论文
共 50 条
  • [31] Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts
    Zhu, Xu
    Trueman, Sheryl
    Straubinger, Robert M.
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (05) : 733 - 746
  • [32] Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts
    Xu Zhu
    Sheryl Trueman
    Robert M. Straubinger
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 733 - 746
  • [33] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR FLUORIDE UPTAKE BY BONE
    RAO, HV
    BELILES, RP
    WHITFORD, GM
    TURNER, CH
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) : 30 - 42
  • [34] Physiologically-based toxicokinetic model of botulinum neurotoxin biodistribution in mice and rats
    Gutting, Bradford
    Gillard, Joseph
    Intano, Gabriel
    COMPUTATIONAL TOXICOLOGY, 2023, 27
  • [35] The development of a stochastic physiologically-based pharmacokinetic model for lead
    Beck, BD
    Mattuck, RL
    Bowers, TS
    Cohen, JT
    O'Flaherty, E
    SCIENCE OF THE TOTAL ENVIRONMENT, 2001, 274 (1-3) : 15 - 19
  • [36] SENSITIVITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS TO VARIATION IN MODEL PARAMETERS - METHYLENE-CHLORIDE
    CLEWELL, HJ
    LEE, TS
    CARPENTER, RL
    RISK ANALYSIS, 1994, 14 (04) : 521 - 531
  • [37] A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles
    Fallon, MS
    Varshney, M
    Dennis, DM
    Chauhan, A
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2004, 31 (05) : 381 - 400
  • [38] A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles
    Marissa S. Fallon
    Manoj Varshney
    Donn M. Dennis
    Anuj Chauhan
    Journal of Pharmacokinetics and Pharmacodynamics, 2004, 31 : 381 - 400
  • [39] Important pharmacokinetic parameters for individualization of 177Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model
    Hardiansyah, Deni
    Kletting, Peter
    Begum, Nusrat J.
    Eiber, Matthias
    Beer, Ambros J.
    Pawiro, Supriyanto A.
    Glatting, Gerhard
    MEDICAL PHYSICS, 2021, 48 (02) : 556 - 568
  • [40] Physiologically-Based Pharmacokinetic-Pharmacodynamic Modeling of 1α,25-Dihydroxyvitamin D3 in Mice
    Ramakrishnan, Vidya
    Yang, Qi Joy
    Quach, Holly P.
    Cao, Yanguang
    Chow, Edwin C. Y.
    Mager, Donald E.
    Pang, K. Sandy
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (02) : 189 - 208